Nektar Therapeutics | NKTR - Debt


Nektar Therapeutics reported $0 in Debt for its fiscal quarter ending in June of 2022.





Debt Change Date
Agios Pharmaceuticals USD 44.52M 4.24M Sep/2025
ALKERMES USD 71.6M 1.08M Sep/2025
Alterity Therapeutics Limited AUD 210.39K 120.67K Jun/2023
Amgen USD 54.59B 1.62B Sep/2025
Baxter International USD 9.71B 13M Sep/2025
BioCryst Pharmaceuticals USD 828.6M 510K Dec/2024
Biogen USD 6.29B 1.7M Dec/2025
Bristol-Myers Squibb USD 51.04B 112M Sep/2025
Cara Therapeutics USD 0 0 Mar/2025
Cipla INR 4.38B 231.9M Mar/2025
Dr.Reddys Laboratories INR 67.73B 9.19B Dec/2025
Eisai JPY 236.67B 49.14B Sep/2025
Eli Lilly USD 42.51B 2.6B Sep/2025
Esperion Therapeutics USD 262.92M 1.76M Sep/2024
Exelixis USD 176.46M 3.38M Sep/2025
Gilead Sciences USD 24.94B 5M Sep/2025
GlaxoSmithKline GBP 17.75B 396M Sep/2025
Grifols EUR 9.23B 626.05M Dec/2024
Halozyme Therapeutics USD 1.51B 1.66M Sep/2025
Incyte USD 40.41M 855K Dec/2025
Ionis Pharmaceuticals USD 2.33B 1.1B Dec/2025
Ironwood Pharmaceuticals USD 583.99M 14.83M Dec/2024
Karyopharm Therapeutics USD 264.09M 39.31M Sep/2024
MacroGenics USD 37.01M 238K Sep/2025
Merck USD 41.37B 5.97B Sep/2025
Nektar Therapeutics USD 0 0 Jun/2022
Neurocrine Biosciences USD 428.4M 10.7M Sep/2025
Novartis USD 32.64B 1.37B Jun/2025
Pfizer USD 60.85B 78M Sep/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Sarepta Therapeutics USD 1.25B 103.69M Sep/2025
Takeda JPY 4.85T 208B Dec/2025
Teva Pharmaceutical Industries USD 17.07B 450M Sep/2025
Xencor USD 69.27M 1.34M Sep/2025